Open AccessParoxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction
Author(s) -
Sarah M. Schumacher,
Erhe Gao,
Weizhong Zhu,
Xiongwen Chen,
J. Kurt Chuprun,
Arthur M. Feldman,
J.J.G. Tesmer,
Walter J. Koch
Publication year - 2015
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.aaa0154
Subject(s) - paroxetine , medicine , myocardial infarction , cardiac dysfunction , cardiac function curve , beta adrenergic receptor kinase , central nervous system , pharmacology , cardiology , heart failure , receptor , serotonin , g protein coupled receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom